Author

A. Bhatia

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Research Focus:cancer & tumor microenvironment· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Chakraborti· 1 shared A. Das· 1 shared C. Choudhury· 1 shared C. Henriquez-Olguin· 1 shared D. Banerjee· 1 shared J. R. Knudsen· 1 shared K. Kaur· 1 shared K. Nambiyar· 1 shared

Activity by Year

2019-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Chakraborti

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Synergistic collagen-condiment: Streptococcal collagen-like (Scl) protein in cell-adhesion and diabetic wound-closure matrix

R. Singh, C. Choudhury, K. Nambiyar, S. Sharma, L. Singh, A. Bhatia, D. Banerjee, A. Das, A. Chakraborti

This study investigates the biomaterial potential of recombinant Streptococcal collagen-like (rScl1) protein, showing its non-cytotoxicity, cell-adhesion support, and efficacy in diabetic wound closure with increased type III collagen.

bioRxiv · Dec 2, 2021 · PreprintMicrobiology

Synthesis, Physiochemical and Biological evaluation of Inclusion Complex of Benzyl Isothiocyanate encapsulated in cyclodextrins for triple negative breast cancer

S. Uppal, R. Kumar, K. Kaur, S. Sareen, A. Bhatia, S. K. Mehta

This study evaluates BITC-CD complexes for triple-negative breast cancer treatment, showing enhanced bioavailability and ROS-mediated cell death.

bioRxiv · Feb 14, 2021 · PreprintCancer Biology

NADPH-oxidase 2 is required for molecular adaptations to high-intensity interval training in skeletal muscle.

C. Henriquez-Olguin, L. Baghersad Renani, L. Arab-Ceschia, S. H. Raun, A. Bhatia, Z. Li, J. R. Knudsen, R. Holmdahl, T. Jensen

This study shows that NOX2 is necessary for skeletal muscle adaptations to high-intensity interval training, including antioxidant defense and mitochondrial changes.

bioRxiv · Feb 6, 2019Physiology